Contract V797D70194
Lxo Us, Inc. · Department Of Veterans Affairs · June 26, 2017
Lxo Us, Inc. was awarded a federal contract by Department Of Veterans Affairs on June 26, 2017 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 27 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 7, 2025. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- V797D70194
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- June 26, 2017
- Latest action
- May 7, 2025
Description
CONTRACT CANCELLATION
Modification timeline
-
May 7, 2025Mod P00028$0
-
March 18, 2025Mod P00027CHANGE-OF-NAME, UPDATED SIGNATORY AUTHORITY FORM$0
-
December 16, 2024Mod P00026TEMPORARY CONTRACT EXTENSION$0
-
December 16, 2024Mod P00024PRODUCT DELETIONS$0
-
November 26, 2024Mod P000252025 PUBLIC LAW PRICING UPDATES$0
-
July 2, 2024Mod P00023TEMPORARY CONTRACT EXTENSION$0
-
April 29, 2024Mod P00022ADMINISTRATIVE CHANGES$0
-
April 24, 2024Mod P00021PRODUCT ADDITION, 42-2A$0
-
April 18, 2024Mod P00020PRODUCT DELETIONS, 42-2A$0
-
January 9, 2024Mod P00019TEMPORARY CONTRACT EXTENSION$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D70194?
Contract V797D70194 is a federal contract awarded to Lxo Us, Inc. by Department Of Veterans Affairs on June 26, 2017 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 27 times since the base award.
Who won contract V797D70194?
Lxo Us, Inc. won contract V797D70194 from Department Of Veterans Affairs.
How much is contract V797D70194 worth?
Contract V797D70194 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.